CCR antagonist BMS-813160, Purity ≥98%

Synonym: BMS-813160; 1286279-29-5; BMS813160; BMS 813160; BMS 813160 - Bio-X; 83U7957287; N-((1R,2S,5R)-5-((1,1-Dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)-Acetamide; CCR antagonist

CAS Number: 1286279-29-5
Compound CID: 51039119

Product Size

2 mg; 5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BMS-813160, soluble in DMSO and ethanol and insoluble in water, stimulates CCR receptors. The receptors bind to chemokines, which are signaling proteins that direct the migration of immune cells to sites of inflammation, infection, or injury.

Molecular Weight

484.65

Molecular Formula

C₂₅H₄₀N₈O₂

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 92 mg/mL (189.82 mM); Water: Insoluble; Ethanol: 92 mg/mL (189.82 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

BMS-813160 is studied as a CCR2/5 antagonist with potential applications in cancer immunotherapy and fibrosis research.

Storage

Store at -20ºC.